We are live on ! Find out more
Jefferies Financial Group

Jefferies Financial Group Portfolio holdings

AUM $13.5B Turnover 52.85%
1-Year Est. Return 36.68%
 

Jefferies Financial Group is the investment banking and capital markets company that was known as Leucadia National until 2018, when it took the name of the bank it merged with in 2013. Leucadia traces back to Ian Cumming and Joseph Steinberg, Harvard Business School graduates who started out at the investment bank Carl Marks & Company and in 1979 took control of Talcott National, renaming it Leucadia the next year. As a holding company it bought and resold businesses, such as the insurer Colonial Penn, acquired in 1991 and sold in two pieces in 1997, and the telecoms company WilTel, acquired in 2003 and sold in 2005. Jefferies itself grew from a small equities trading shop into a full-service investment bank, and Richard Handler became chief executive of the combined company in 2013.

This Fund
S&P 500
This Quarter Est. Return
+3.06%
1 Year Est. Return
+36.68%
3 Year Est. Return
+146.37%
5 Year Est. Return
+81.72%
10 Year Est. Return
+581.29%
AUM
$13.5B
AUM Growth
-$1.68B
Cap. Flow
-$3.53B
Cap. Flow %
-26.13%
Top 10 Hldgs %
33.68%
Holding
1,968
New
337
Increased
289
Reduced
401
Closed
703
Avg Time Held Equity + Options
0.9 years
Top 10 Avg Time Held Equity + Options
1.5 years
Top 20 Avg Time Held Equity + Options
1 year
Avg Time Held Equity only
1 year
Top 10 Avg Time Held Equity only
1.1 years
Top 20 Avg Time Held Equity only
0.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 59.53%
2 Healthcare 11.13%
3 Technology 8.29%
4 Industrials 4.73%
5 Financials 4.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SLB icon
1026
PUT
SLB
SLB
$72.3B
$244K ﹤0.01%
5,000
-23,000
-82% -$1.19M
2025 Q2
5 quarters
TNL icon
1027
Travel + Leisure
TNL
$4.7B
$240K ﹤0.01%
+3,875
New +$276K
2026 Q3
0 quarters
TRIP icon
1028
TripAdvisor
TRIP
$828M
$239K ﹤0.01%
+28,603
New +$324K
2026 Q3
0 quarters
ISRG icon
1029
Intuitive Surgical
ISRG
$149B
$237K ﹤0.01%
584
-3,042
-84% -$1.16M
2024 Q3
8 quarters
BTE icon
1030
Baytex Energy
BTE
$2.84B
$237K ﹤0.01%
52,355
-7,527
-13% -$33.8K
2023 Q2
13 quarters
DHX icon
1031
DHI Group
DHX
$175M
$235K ﹤0.01%
+50,000
New +$212K
2026 Q3
0 quarters
TTRX icon
1032
Turn Therapeutics
TTRX
$261M
$235K ﹤0.01%
16,300
– –
2026 Q2
1 quarter
ORGO icon
1033
Organogenesis Holdings
ORGO
$105M
$233K ﹤0.01%
+170,000
New +$334K
2026 Q3
0 quarters
SAM icon
1034
Boston Beer
SAM
$2.28B
$230K ﹤0.01%
1,401
-3,099
-69% -$549K
2026 Q1
2 quarters
IMO icon
1035
Imperial Oil
IMO
$59.7B
$227K ﹤0.01%
1,844
-38
-2% -$4.84K
2023 Q1
14 quarters
FATE icon
1036
Fate Therapeutics
FATE
$124M
$227K ﹤0.01%
95,600
+36,478
+62% +$94.3K
2026 Q2
1 quarter
BB icon
1037
BlackBerry
BB
$4.79B
$226K ﹤0.01%
+25,000
New +$220K
2026 Q3
0 quarters
DHT icon
1038
PUT
DHT Holdings
DHT
$3.46B
$226K ﹤0.01%
+10,000
New +$195K
2026 Q3
0 quarters
SHOO icon
1039
CALL
Steven Madden
SHOO
$2.94B
$224K ﹤0.01%
5,000
-8,700
-64% -$384K
2026 Q2
1 quarter
COIN icon
1040
CALL
Coinbase
COIN
$30.5B
$224K ﹤0.01%
+1,200
New +$204K
2026 Q3
0 quarters
VNET icon
1041
VNET Group
VNET
$730M
$222K ﹤0.01%
240,000
+115,026
+92% +$807K
2025 Q4
3 quarters
CNXC icon
1042
Concentrix
CNXC
$1.87B
$222K ﹤0.01%
8,878
-30,343
-77% -$794K
2025 Q3
4 quarters
JBLU icon
1043
JetBlue
JBLU
$1.34B
$221K ﹤0.01%
52,300
+39,223
+300% +$203K
2025 Q4
3 quarters
HURC icon
1044
Hurco Companies
HURC
$124M
$216K ﹤0.01%
+10,000
New +$221K
2026 Q3
0 quarters
FEZ icon
1045
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.11B
$210K ﹤0.01%
3,125
-728
-19% -$50.7K
2025 Q3
4 quarters
W icon
1046
Wayfair
W
$14.6B
– –
0
– –
2026 Q3
0 quarters
PHR icon
1047
Phreesia
PHR
$780M
$201K ﹤0.01%
19,500
-37,500
-66% -$412K
2025 Q4
3 quarters
PHR icon
1048
PUT
Phreesia
PHR
$780M
$201K ﹤0.01%
19,500
-40,000
-67% -$440K
2025 Q4
3 quarters
KD icon
1049
Kyndryl
KD
$3.49B
$197K ﹤0.01%
17,500
-70,568
-80% -$896K
2026 Q2
1 quarter
GPACU icon
1050
General Purpose Acquisition Corp Units
GPACU
$195K ﹤0.01%
184,000
– –
2025 Q4
3 quarters

Similar funds

Jefferies Financial Group's Q3 2026 Portfolio in Review

As of Q3 2026, Jefferies Financial Group held 1,968 positions worth $13.5B, down 11% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jefferies Financial Group withdrew a net $3.53B in Q3 2026, closing 703 positions and reducing 401 holdings. Its most notable exit was PTC Therapeutics, an estimated $111M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 50% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Jefferies Financial Group opened a new position in Emcor worth $40.1M.

  • Jefferies Financial Group's largest Q3 2026 buy was Emcor: 53,175 shares worth $40.1M.
  • Jefferies Financial Group added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2026, an estimated $204M increase.
  • Jefferies Financial Group's biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $640M.
  • Jefferies Financial Group fully exited PTC Therapeutics in Q3 2026, selling an estimated $111M.
  • Jefferies Financial Group's ten largest holdings make up 34% of its $13.5B portfolio in Q3 2026.
  • Jefferies Financial Group opened 337 new positions and closed 703 in Q3 2026.
  • Jefferies Financial Group's portfolio value fell 11% quarter-over-quarter to $13.5B.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.